skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:028422/0466   Pages: 19
Recorded: 06/21/2012
Attorney Dkt #:G621 ARDIAN NAME CHANGE
Conveyance: CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Total properties: 5
1
Patent #:
NONE
Issue Dt:
Application #:
12159306
Filing Dt:
11/11/2008
Publication #:
Pub Dt:
03/19/2009
Title:
METHODS AND SYSTEMS FOR THERMALLY-INDUCED RENAL NEUROMODULATION
2
Patent #:
NONE
Issue Dt:
Application #:
12495691
Filing Dt:
06/30/2009
Publication #:
Pub Dt:
07/01/2010
Title:
APPARATUS, SYSTEMS, AND METHODS FOR ACHIEVING INTRAVASCULAR, THERMALLY-INDUCED RENAL NEUROMODULATION
3
Patent #:
Issue Dt:
02/18/2014
Application #:
12545648
Filing Dt:
08/21/2009
Publication #:
Pub Dt:
07/01/2010
Title:
APPARATUS, SYSTEMS, AND METHODS FOR ACHIEVING INTRAVASCULAR, THERMALLY-INDUCED RENAL NEUROMODULATION
4
Patent #:
Issue Dt:
10/28/2014
Application #:
12790639
Filing Dt:
05/28/2010
Publication #:
Pub Dt:
10/27/2011
Title:
CATHETER APPARATUSES, SYSTEMS, AND METHODS FOR RENAL NEUROMODULATION
5
Patent #:
Issue Dt:
05/20/2014
Application #:
12871457
Filing Dt:
08/30/2010
Publication #:
Pub Dt:
10/27/2011
Title:
MULTI-DIRECTIONAL DEFLECTABLE CATHETER APPARATUSES, SYSTEMS, AND METHODS FOR RENAL NEUROMODULATION
Assignors
1
Exec Dt:
01/21/2011
2
Exec Dt:
02/03/2012
Assignee
1
102 RUE DES MARAICHERS
LUXEMBOURG, LUXEMBOURG L-2124
Correspondence name and address
MEDTRONIC VASCULAR INC.
3576 UNOCAL PLACE
IP LEGAL DEPARTMENT
SANTA ROSA, CA 95403

Search Results as of: 06/01/2024 05:53 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT